Short-acting nifedipine and risk of stroke in elderly hypertensive patients

Neurology

Volumn 77, Issue 13, 2011, Pages 1229-1234

  Jung, S Y ^a   Choi, N K ^a   Kim, J Y ^a   Chang, Y ^a   Song, H J ^a   Lee, J ^a   Park, B J ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; NIFEDIPINE; VASODILATOR AGENT;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DYSLIPIDEMIA; EMERGENCY WARD; FEMALE; GERIATRIC PATIENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; INTERNATIONAL CLASSIFICATION OF DISEASES; ISCHEMIC HEART DISEASE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PNEUMONIA; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; STROKE PATIENT; TREATMENT DURATION; CONFIDENCE INTERVAL; CROSSOVER PROCEDURE; PUBLIC HEALTH; RETROSPECTIVE STUDY; RISK; RISK FACTOR; SOUTH KOREA; STATISTICS; TIME;

AGED; AGED, 80 AND OVER; CONFIDENCE INTERVALS; CROSS-OVER STUDIES; FEMALE; HOSPITALIZATION; HUMANS; MALE; NATIONAL HEALTH PROGRAMS; NIFEDIPINE; ODDS RATIO; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; TIME FACTORS; VASODILATOR AGENTS;

EID: 82255182420     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318230201a     Document Type: Article

References (25)

1. Papadopoulos DP, Papademetriou V. Aggressive blood pressure control and stroke prevention: role of calcium channel blockers. J Hypertens 2008;26:844-852. (Pubitemid 351520967)
2. Fischberg GM, Lozano E, Rajamani K, Ameriso S, Fisher MJ. Stroke precipitated by moderate blood pressure reduction. J Emerg Med 2000;19:339-346.
3. Nobile-Orazio E, Sterzi R. Cerebral ischaemia after nifedipine treatment. BMJ (Clin Res Ed) 1981;283:948. (Pubitemid 11020477)
4. Opie LH, Messerli FH. Nifedipine and mortality: Grave defects in the dossier. Circulation 1995;92:1068-1073.
5. Brickman AM, Reitz C, Luchsinger JA, et al. Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol 2010;67:564-569.
6. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003;163: 2716-2724. (Pubitemid 37517412)
7. Lin HY, Liao CC, Cheng SH, Wang PC, Hsueh YS. Association of potentially inappropriate medication use with adverse outcomes in ambulatory elderly patients with chronic diseases: experience in a Taiwanese medical setting. Drugs Aging 2008;25:49-59.
8. Sequeira RP, Jassim Al Khaja KA, Mathur VS. Extent of use of immediate-release formulations of calcium channel blockers as antihypertensive monotherapy by primary care physicians: multicentric study from Bahrain. J Postgrad Med 2002;48:172-175. (Pubitemid 35386069)
9. Sweileh WM. Treatment of complicated and uncomplicated hypertension with nifedipine in Palestine. Saudi Med J 2005;26:78-83. (Pubitemid 40372505)
10. Chen YC, Hwang SJ, Lai HY, et al. Potentially inappropriate medication for emergency department visits by elderly patients in Taiwan. Pharmacoepidemiol Drug Saf 2009; 18:53-61.
11. Grossman E, Messerli FH, Grodzicki T, Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA 1996;276:1328-1331. (Pubitemid 26346933)
12. Schwartz M, Naschitz JE, Yeshurun D, Sharf B. Oral nifedipine in the treatment of hypertensive urgency: cerebrovascular accident following a single dose (I). Arch Intern Med 1990;150:686-687. (Pubitemid 20122028)
13. Choi NK, Chang Y, Choi YK, Hahn S, Park BJ. Signal detection of rosuvastatin compared to other statins: datamining study using national health insurance claims database. Pharmacoepidemiol Drug Saf 2010;19:238-246.
14. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991;133:144-153.
15. Maclure M, Mittleman MA. Should we use a casecrossover design? Annu Rev Public Health 2000;21:193-221.
16. Poole-Wilson PA, Lubsen J, Kirwan BA, et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet 2004;364:849-857.
17. Spence JD, Paulson OB, Strangaard S. Hypertension and stroke. In: Messerli FH, ed. The ABCs of Antihypertensive Therapy. New York, NY: Lippincott Williams amp; Wilkins; 2000:279-296.
18. Furberg CD, Psaty BM, Meyer JV. Nifedipine. Doserelated increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-1331.
19. Maxwell CJ, Hogan DB, Campbell NR, Ebly EM. Nifedipine and mortality risk in the elderly: relevance of drug formulation, dose and duration. Pharmacoepidemiol Drug Saf 2000;9:11-23. (Pubitemid 30157601)
20. Ishibashi Y, Shimada T, Yoshitomi H, et al. Sublingual nifedipine in elderly patients: even a low dose induces myocardial ischaemia. Clin Exp Pharmacol Physiol 1999; 26:404-410. (Pubitemid 29306956)
21. O'Mailia JJ, Sander GE, Giles TD. Nifedipine-associated myocardial ischemia or infarction in the treatment of hypertensive urgencies. Ann Intern Med 1987;107:185-186. (Pubitemid 17137852)
22. Michalewicz L, Messerli FH. Cardiac effects of calcium antagonists in systemic hypertension. Am J Cardiol 1997; 79:39-46; discussion 47-38. (Pubitemid 27293034)
23. Park JK, Kim KS, Kim CB, et al. The accuracy of ICD codes for cerebrovascular diseases in medical insurance claims. Korean J Prev Med 2000;33:76-82.
24. Welfare MoHa. Pilot Test of National Cardiovascular Disease Surveillance System. Seoul, Korea: Ministry of Health and Welfare; 2000.
25. Motheral BR, Fairman KA. The use of claims databases for outcomes research: rationale, challenges, and strategies. Clin Ther 1997;19:346-366. (Pubitemid 27239651)